Five years ago, the CEO of one of the largest pain clinic companies in the Southeast was sentenced to more than three years in prison after being convicted in a $4 million illegal kickback scheme. But after just four months behind bars, John Estin Davis walked free. President Donald Trump commuted Davis’ sentence in the…
By increasing the availability of services through flexible payment methods, providers have an opportunity to expand their customer base and establish themselves as trusted partners in the wellness journey. The post Pairing Wellness Needs With Financing Solutions: How a Second Look May Increase Accessibility to Services appeared first on MedCity News.
AstraZeneca’s Datroway, an antibody drug conjugate (ADC), is now FDA approved for advanced cases of breast cancer that is HR positive and HER2 negative. Datroway targets TROP2, the same cancer protein addressed by Trodelvy, a Gilead Sciences ADC also approved for breast cancer. The post AstraZeneca, Daiichi Sankyo ADC Lands FDA Approval in Advanced Breast…
On May 2, 2025, the White House released preliminary details of its FY26 budget request, including funding for global health activities at the State Department, U.S. Agency for International Development (USAID), Centers for Disease Control and Prevention (CDC), and the Fogarty International Center (FIC) at National Institutes of Health (NIH). While funding amounts for most…More
Hone Health’s Series A round included participation from Tribe Capital, PIF, Republic Capital, Vibe VC, Humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs and Agent Capital. In total, the company has raised $39 million. The post Telehealth Clinic Hone Health Secures $33M, Acquires Home Health Company appeared first on MedCity News.
Now, more than ever, healthcare organizations must strive to innovate to ensure continuous patient care delivery while keeping medical staff safe. The post Healthcare Organizations Can, and Should, Provide Continuous Patient Care with the Right Technology appeared first on MedCity News.
[Sponsored] The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today! The post Eliminating Blind Spots in the Patient Journey appeared first on MedCity News.
Zevra Therapeutics received a priority review voucher for Miplyffa, the first FDA-approved treatment for the rare metabolic disorder Niemann Pick disease type C. Though Zevra has other drug candidates that could benefit from the voucher, the biotech is selling it to an undisclosed buyer. The post Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug…
Healthcare organizations are starting to implement AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and…
A couple of weeks back Transcarent completed its $630m acquisition of Accolade. But CEO Glen Tullman calls it a merger for a reason because Accolade brings people, products and clients that Transcarent didn’t have. Glen got in deep about Transcarent’s new product set in terms of its AI fueled navigation, primary care, weight management, cancer…